Guía Práctica en Diagnóstico Prenatal, Revisión Bibliográfica

28. Dunne MG, Johnson ML. The ultrasonic demostration of fetal anormalities in utero. Reprod Med 1979;23/4:195-206.
29. Hobbins JC, Grannum PA,Berkowitz BC y cols. Ultrasound in the diagnosis of congenital anomalies. Am J Obstet Gynecol 1979;134:331-345.
30. Bonilla F. Diagnóstico prenatal de las malformaciones fetales.Barcelona: Jims,1983.
31. Carrera JM. Ecografía obstétrica, 2 edición. Barcelona Salvat Editores, 1985.
32. Carrera JM. Control ecográfico sistemático para el diagnóstico de malformaciones fetales: 24 años de experiencia. Prog Diag Prenat 1994;6:379-389.
33. Westin B. Hysteroscipy in early pregnancy. Lancet 1954;2:872.
34. Hobbins JG, Mahoney MJ. In utero diagnosis of hemoglobinopathies technic for obtainig fetal blood. N Engl J Med 1973;290:1065-1067.
35. Hobbins JC,Mahoney MJ,Goldstein LA. New method of intrauterine evluation by thecombined use of fetoscopy and ultasound. Aqm J Obstet Gynecol 1973;118:1069-1072.
36. Phillips JM. Fetoscopy. An overview . J Reprod Md 1975;15:69-72
37. Rocker I,Lawrence KM. Intrauterine fetal visualitation and blood sampling. En: Marken JD, Stenge-Rutkkkowski S, Schiwinder E, eds. Prenatal diagnosis Stuttgart: Ferdinand Enke, 1978.
38. Rodeck CH. Fetoscopy guided by real time ultrasound for pure fetal blood samples, fetal skin samples and examination of the fetus in utero. Br J Obstet Gynaecol 1980;87:449-456.
39. Rodeck CH. Value of fetoscopy in prenatal diagnosis. J Roy Soc Med 1980;75:29-33.
40, Rodeck CH, Eadi RAJ, Gosden CM. Prenatal diagnosis of epydermolysis bullosa letalis. Lancet 1980; 1:949-952.
41. Valenti C. Endoamnioscopio and fetal biopsy: A new technique. Am J Obstet Gynecol 1972:1:949952
42. Rodeck CH, Patrick AD, Pembrey ME y cols. Fetal liver biopsy for prenatal diagnosis of ornithine carbamyltransferace deficiency. Lancet 1982;1:189-194.
43. Valenti C. Antenatal detection of hemoglobinopathies. AM J Obstet Gynecol 1973;115:851
44. Rodeck CH, Campbell S. Sampling pure fetal blood by fetoscopy in second trimester of pregnacy. BR Med J 1978;11:728-730.
45. Rodeck CH, Campbell S. Umbilical cord insertion as a source of pure fetal blood for prenatal diagnosis. Lancet 1979;1:1244-1245.
46. Nicolaides KH,Rodeck CH. The use of fetoscopy in the management of severe Rhesus isoinmunisation. Nápoles: Intrnational Symposium on Inmuniphysiology of reproduction, 1982.
47. Kullander S, Sandahl B. Fetal chromosome analysis after transcevical placental biopsies during early pregnancy. Acta Obstet Gynecol Scand 1973;52:355-359.
48. Kazy Z, Rozovsky IS, Bakarev VA. Chorion biopsy in early pregnancy: a new method of early prenatal diagnosis for inherited disorders. Prenatal diagnosis 1982;2:39-45.
49. Ward RHT, Modell B, Petrou M y cols. Method of sampling chorionic villi in first trimester of pregnancy under guidance of real time ultrasound. Br Med J 1983;286:1542-1544.
50. Rodeck CH, Morsman JM, Gosden CM. The development of an improve technique for first trimester microsampling of chorion. Br Med J 1983;90:1113-1118.
51. Daffos F, Capella-Pavlovsky M, Forestier F. A new procedure for pure fetal bloodmsampling in utero. Prenat Diag 1983;3
52. Bennett P, Moore G. Biología molecular para perinatólogos. Barcelona Masson , 1994.
53. Arbert W, Smith H, Mathaus D. Citados de biología molecular. Barcelona: Masson 1.994.
54. Berg P (1972). Citado por Bennett. Biología molecular para perinatólogos.
55. Southern EM (1975). Citado por Bennett. Biología molecular para perinatólogos. Barcelona Masson.1994
56. Saiki RK, Scharf S, Faloona F y cols. Enzymatic amplification of B-globin genomic sequences an restriction  site analysis for of sickle cell anemia. Science 1985;239:1350-1354.
57. Levi S, Hyjazi Y, Shaaps Jp. Sensivity and especifity of routine antenatal screening for congenital anomalies by ultrasound: tha Belgian multicentry study. Ulta Obstet Gynecol 1991;1:102-110
58. Eik-Nes SA, Okland O,Aure JC. Ultrasound screening in pregnancy. Lancet 1984;1:1347.
59. Cuckle HS, Wald NJ, Lindembaumn Rh. Maternal serum alpha fetoprotein measuremnet: a screening test for Down Syndrome. Lancet 1984;1:926-929.
60. Merkatz IR, Nitowsky HM,Macri JM, Johnson WT, An association between low maternal serum AFP and fetal chromosome abnormalities. Am J Obstet Gynecol 1984;148:885.894.
61. Bogart MH,Pandian MR, Jones OW. Abnormal materialserum chorionic gonadotropin levels in normalities pregnancies with fetal chromosomal abnormalities. Prenat Diag 1987;7:623-630.
62. Canick JA, Knight Gjk, Palomaki GE y cols. Lowsecond trimester maternal serum unconjugated oestriol in pregnancies with Down´s syndrome. Br J Obstet Gynecol 1988;95:330-333.
63. Benacerraf BR, Gelman R, Frigoletto FDJ. A sonographic sign for the detection in the second trimester fetuses with Down´s syndrome. Am J Obstet Gynecol 1985;151:1078.
64. Benacerraf BR, Gelman R, Frogoleto FDJ. Sonographic identification of second trimester fetuses with Down´s syndrome. N Engl J Med 1987;317:1371.
65. Veiga A, Santaló J, Vidal F, Calderón G, Gimenez C, Boada M, Egozcue J, Barri PN. Twin pregnancy after preimplantation diagnosis for sex selection. Hum Reprod 1994;9:2156-2159.
66. Handyside AN, Pattinson Jk, Penketh RJ,Decanthy JD, Winston RM. Biopsy of human preimplantation embryos and sexing by DNA amplification. Lancet 1989;i:347-349.
67. Handyside AH, Kontagianni EH, Winston RM. Pregnancies from biopsied human preimplantation sexed by Y- specific DNA amplifications. Nature 1990; 344:768-770.
68. Dokars A, Sargent IL, Barlow DH. Blastocyst biopsy following IVE. Prenat Diag 1992;12
69. Pergament E. Preimplantation diagnosis: a patient perspective. Prenat Diag. 1991,11:493-500
70. Bianchi DW, Flint AF,Pizzimenti MF, Knon JHM, Latt SA. Isolation of fetal DNA from nucleated eritrocytes in maternal blood. Proc Natl Acad Sci USA 1990;87:3279-3283.
71. De la Riva AM, Marqués Gubern A. Prevención y diagnóstico prenatal de los defectos del tubo neural. Cir Pediatr 1990;3:35-36.
72. Martinez Frias ML. Defectos congénitos en España. Diez años de vigilancia epidemiológica. Estudios sanitarios. Dirección general de planificación sanitaria. Ministerio de sanidad y consumo. Madrid, 1989.
73. Hibbard BM. The role of folic acid in pregnancy: with particular reference to anaemia, abruption and abortion. J Obstet Gynaecol Br Commomv 71:529-42,1964
74. Hibbard DE, Smithells RW. Folic acid metabolism and human embryophaty. Lancet 1:1254, 1965.
75. Nelson MM, Forfar JO. Associations between drugs administered during pregnancy and congenital abnormalities of the fetus. Br J Med 1:523-527,1971.
76. Smithells RW, Shepard S, Schorah CJ, et al. Possible prevention of neural-tube defects by periconceptional vitamin supplemntation. Lancet 1: 339.340, 1980
77. Smithells RW et al. Apparent prevention of neural tube defects by periconceptional vitamin supplementation. Arch Dis Child 56:911-8, 1981.
78. ECEMEC. Utilización periconcepcional del ácido fólico y prevención de defectos del tubo neural. Informe de septiembre de 1993.
79. CDC. Economic burden of spina bifida- United States, 1980-1990.MMWR 38:264-267,1989.
80. Martinez-Frías ML and Salvador J. Epidemiological aspects of prenatal exposure to high doses of vitamin A in Spain. Eur J Epidemiol 6:118-123,1990.
81. Hagard S. Carter F. Prevnting the birth of infants Down Syndrome: a cost-benefit analysis. Br Med J 1976;i:753-756.
82. Henderson JB. Economic evaluation of screening for fetal and genetic abnormality. King´s Fund Consensus conference on prenatal screening. London: King´s fund institute, 1987.
83. MerkatzIR, Nitowsky HM, Macril JN. An association between low maternal serum AFP and fetal chromosomal anomalies. Am J Obstet Gynecol 1984;148:886.
84. DiMaio MS, Baumgarten A, Greenstein RM, Saal HM, Mahoney MI. Screening for fetal Down´s Syndrome in pregnancy by measuring maternal serum AFP levels. N Engl J Med 1987;317:342-346.
85. Bogart MH, Pandian MR, Jones OW. Abnormal maternal serum HCG in pregnacies wiyh fetal chromosome anomalies. Prenat Diagn 1987;623-630.
86. Canik JA, Knight GJ, Palomaki GE. Low second trimester serum and unconjugated estriol in pregnancies with Down Syndrome. BrJObstet Gynec 1988;95:330-333
87. Snijders RJM, Sebire NJ, Nicolaides KH. Maternal age and gestational age-specific risk for chromosomal defects. Fetal Diag Ther 1995.
88. Hook EB, Fabia JJ. Frequency of Dwn Syndrome in livebirths by single -year maternal age interval: Results of a Massachusetts study. Teratology 1978;17:223-8.
89. Macri JN, Spencer K, Garber K, Buchanan P, Say B, Carpenter NJ, Muller F, Boué A. Maternal serum free B-HCG screening. Results of studies including 480 cases of Down´s Syndrome. Prenat Diag 1994;14:97-103
90. Milusky A, Nebiolo L, Bellet D. Maternal screening for cromosome defects. Human chorionic gonadotropin versus uts free beta unit. Fetal Diagn Ther 1993;8:221-224
91. Crossley JA, Aitken DA, Connor JM. Second trimester unconjutgated estriol levels in maternal serum from chromosomaly abnormal pregnancies using an optimized assay. Prenat Diagn 1993;13:271-180.
92. Spencer K, Coombes EJ, Mellards AS, Ward AM. Free beta-HCG in Down´s Syndrome screening. A multicenter study of its role compared wiyh bioquemical markers. Ann in bioquem 1992;29:508518.
93. Krantz DA, Larse JW, Macri J. First trimester Down Syndrome screening: Free beta human chorionic gonadotropin and pregnancy- associated plasma protein A . Am J Obste Gynecol 1996; 174:612-6.
94. Brambati B, Tului L, Bonacci I, Grutz Kinkas JG, y cols . First trimester free beta hCG and PAPP-A in pregnancies with aneuploid fetuses. Prenat Diag 1994; 14: 1043-7.
95. Wallace EM, Swanston LA, McNeilly AS, Aschby JP, y cols. Second trimester screening for Down syndrome using dimeric inhibin A . Clin Endocr ( Oxf) 1996; 44:15-21.
96. Cabero L, Farrán I. Fisiología de los marcadores bioquímicos maternos. Prog Diagn Pren 1994;6:427-432.
97. Fortuny A, Casals E. Triple screening en sangre materna. Bases, indicaciones y resultados. Prog Diag Pren 1994;6:442-449.
98. Nicolaides KH, Azar G, Byrne D, Mansur C, Marks K. Fetal Nuchal Translucency: Ultrasound screening for chromosomal defects in first trimester of pregnancy. Br Med J 1992; 304:867-9
99. Nicolaides KH, Brizot ML, Snijdres RJM. Fetal nuchal translucency: Ultrasound screening for fetal trisomy in the first trimester of pregnancy. Br J Obstet Gynaecol 1994b; 101:782-6
100. Pandya PP, Brizot ML, Kuhn P, Snijders RJM, Nicolaides KH. First trimester fetal nuchal translucency thickness and risk for trisomies. Obstet Gynecol 1994; 84:420-3.
101. Pandya PP, Goldberg H, Walton B, Reedle A, Shelley S, Snijders RJM, Nicolaides KH. The implementation of first trimester scanning at 10-13 weeks gestation and the measurement of fetal nuchal translucency thickness in two maternity units.Ultrasound Obstet Gynecol 1995b; 5:20-5
102. Pandya PP, Gilbert F, Snijders RJM, Nicolaides KH. Nuchal translucency thickness and crown – rupm length in twin pregnancies with chromosomaly abnormal fetuses. J Ultrasound Med 1995c.
103. Pandya PP, Kondylios A, Gilbert L, Snijders RJM, Nicolaides KH. Chromosomal defects and outcome in 1015 fetuses with increase nuchal translucency. Ultrasound Obstet gynecol 1995 d 5:1519
104. Pandya PP, Snijders RJM, Johnson S, Nicolaides KH. Natural history of trisomy 21 fetuses with fetal nuchal translucency. Ultrasound Obstet Gynecol 1995e.
105. Benacerraf BR, Gelman R, Frigoletto FD. Sonographic identification of second-trimester fetuses with Down´s syndrome. N Engl J Med 1987; 317:1371-6
106. Benacerraf BR, Harlow B, Frigoletto FD. A choroid plexus cysts and indication for secon trimester amniocentesis ?. Am J Obstet Gynecol 1990ª;162:1001-6
107. Benacerraf BR, Mandell J, Stroff JA, Harlow BL, Frigoletto FD. Fetal pyelectasis: A possible association with Down syndrome. Obstet Gynecol 1990b;76:58-60.
108. Benaceraff BR, Nadel A, Bromley B. Identification of second trimester fetuses with autosomal trisomy by use of a sonographic scoring index. Radiology 1994;193:135-40
109. Kirk JS, Comstock CH, Fassnacht MA. Routine measurement of nuchal thickness in the second trimester. J Maternal fetal medicine 1992;1:82-6
110. Levi S, Hyjazi Y, Schaaps JP, Defoort P, Colon R, Buekens P. Sensinity and specificity of routine antenatal screening for congenital anomalies by ultrasound: The belgian multicentic study. Ultrasound Obstet Gynecol 1991;1:102-10
111. Hill LM, Guzick D, Belfar HL, Hixon J, Rivello D, Rusnak J. The current role of sonography in the detection of Down syndrome. Obstet Gynecol 1989;620-3
112. Dicke JM, Gray DL, Songster GS, Crane JP. Fetal biometry as a screening tool for the detection of chromosomally abnormal pregnancies. Obstet Gynecol 1989;74:726-9
113. Biagiotti R, Periti E, Cariati E. Humerus and femur length in fetuses with Down syndrome. Pren Diag 1994;429-34
114. Bianchi DW y cols. isolation of fetal DNA from nucleated erythocytes in maternal blood. Prog Natl Acad Sci USA 1990; 87:3279-83.
115. Bianchi DW y cols. Detection of fetal cells with 47,XXY+21 karyotype in maternal peripheral blood. Hum Genet 1995; 90:368-70.
116. Bianchi y cols. Male fetal progenitor cells perisit in maternal blood for as long as 27 years post partum. Prog Natl Acad Sci USA 1996; 93:705-8.
117. Golberg JD. Fetal Cells in maternal circulations: Progress in analysis odd a rare event. Am J Hum Genet 1997;61:806-9
118. Hamada CS y cols. Fetal nucleated cells in maternal peripheral blood. Frecuency and relationship to gestational age. Hum Genet 1993;91:427-32
119. Pezzolo C y cols. Prenatal diagnosis of triploidy using fetal cells in the maternal circulation. Prenat diagn 1997; 15:933.
120. Walknowska J y cols. Practical and theoretical implication of fetal /maternal lymphoocytes transfer. Lancet 1969; 1:1119-22.
121. Cameron Ad, Murphy KW, McNay MB, Mathers AM, Kingdom J, Aitken DA, Crossley J, Imrie S, Lowther G. Midtrimester chorionic villus sampling: an alternative approach ? Am J Obstet Gynecol 1994;171:1035-7
122. Canadian collaborative CVS-amniocentesis clinical trial group. Multicentre randomised clinical trial of chorion villus sampling and amniocentesis. Lancet 1989;i:1-6
123. Firth HV, Boyd PA, Chamberlain P, Mackenzie IZ, Lindenbaum RH,Huson SM. Severe limb abnormalities after chorion villous sampling at 56-66 day´s gestation. Lancet 1991;337:762-3
124. Firth HV, Boyd PA, Chamberlain PF, Mackenzie IZ,Morris-Kay GM,Huson SM. Analysis of limb reduction defects in babies exposed to chorion villus sampling. Lancet 1994;343:1069-71
125. Froster-Iskenius UG, Baird PA. Limb reduction defects in over one million consecuyive livebirths. Teratology 1989;39:127-35
126. Holzgreve W, Miny P, Gerlach B. Benefits for rapid fetal karyotyping in the second and third trimester in high risk pregnancies. Am J Obstet Gynecol 1990;1188-92
127. Kuliev AM, Modell B, Jackson L, Simpson JL, Brambati B, Rhoads G, Froster U, Berlinsky Y, Smith – Jensen S, Holzgreve W, Ginsberg N, Ammala P, Dumez Y. Risk evaluation of CVS. Prenat Diagn 1993; 13:197-209.
128. Lippman A, Tomkins J, Shime J, Hamerton JL. Canadian multicentre randomized clinical trial of chorion villus sampling and amniocentesis. Prenat Diagn 1992;12:385-476.
129. MRC working party on the evaluation of chorion villus sampling. Medical research council european trial of chorion villus sampling. Lancet 1991;337:1491-9
130. Nicolaides KH, Brizot M, Patel F, Snidjers R. Camparison of chorionic villus sampling and amniocentesis for fetal karyotyping at 10-13 week´s gestation. Lancet 1994; 344:435-9
131. Pandya PP, Kuhn P, Brizot M, Cardy DL, Nicolaides KH. Rapid detection of chromosome aneuploidies in fetal blood and chorionic villi by fluorescence in situ hybridisation. Br J Obstet Gynecol 1994;101:493-7.
132. Dumez I. Embryoscopy in continuing pregnancies. Presentado en el Annual Meeting of the International Fetal Medicine and Surgery Society. Evian 1.992.
133. Quintero RA, Abuhamad A, Hobbins JC, Mahonney MJ. Transabdominal thin gauge embryo fetoscopy : A technique for early prenatal diagnosis and its usses in tha diagnosis of a case of Meckel Gruber Syndrome. Am J Obstet Gynecol 1993;168:1552-1557.
134. Cullen MT, Reece EA, Whethaam J, Hobbins JC. Embryoscopy: Description and utility of a new technique. Am J Obstet Gynecol.1990 162:82-86.
135. Reece EA, Rothmensch S, Whethan J, et al : Embryoscopy : A clser look at first-trimester diagnosis and treatment . AM J Obstet Gynecol 661:775-780, 1992.
136. Penso CA, Frigoletto FD Jr. Early amniocentesis. Sem Perinatol 1990; 14:465.
137. Penso CA, Sandtrom MM, Garber MF, Ladoulis M, Stryker JM, Benacerraff BR. Early amniocentesis : Report of 407 cases with neonatal follow up. Obstet Gynecol 1990;76:1032.
138. Corona M, Mellado F, Sole MT, Argemi S. Amniocnetesis ultraprecoz. Estudio de 100 casos y seguimiento neonatal. Prog Diagn Prenat 1993;4:111.
139. Farran I, Pla F, Mediano C, Canet Y, Carreras E, De la Riva AM, Cabero L. Amniocentesis precoz: resultados en 206 casos con seguimiento neonatal. Prog Diagn Prenat 1993;3:73.
140. Hackett G, Smith J, Revello M y cols. Early amniocentesis at 11-14 week´s gestation for the diagnosis of fetal chromosomal abnormality- a clinical evaluation. Prenat Diag 1991;11;311.
141. I Farrán. Amniocentesis. En: Ecografía obstétrica. Criteiros biométricos y funcionales. Ramos JM, Ferrer M, Carreras E, Farrán I, Borrell A. Harcourt Brace 1996:391-399.
142. Steele MW, Berg WT. Chromosome analysis of human amniotic fluid cells. Lancet 19966;i:383.
143. Valenti C, Shutta EJ, Kehaty T. Prenatal Diagnosis of Down Syndrome. Lancet 1968;ii:220
144. Nadler HL, Gerbie AB. Role of amniocentesis in intrauterine detection of genetic disorders. N Eng J Med 1970;282:596.
145. Curtis JD, Cohen WM, Richardson HB, Withe CH. The importance of placental location preceding amniocentesis. Obstet Gynecol 1972;40:194.
146. An assesment of the hazards of amniocentesis. Report to the medical research council by their Working Party on amniocentesis. Br J Obstet Gynaecol 1977 ;85 (supl 2 ):1-41.
147. Romero R, Jeanty P, Reece EA, Grannum P, Bracken M, Berkowitz R, Hobbins JC. Sonographically monitored amniocentesis of decrease intraoperative complications. Obstet Gynecol 1985;65:426.
148. Tabor A, Philip J, Matser M, Bang J, Obel EB, Nogaard – Pedersen B. Randomized controled trial of genetic amniocentesis in 4606 low risk women . Lancet 1986;i: 1287.
149. Elias S, Gerbie AB, Simpson JL, Nadler HL, Sabbagha RE, Shkolnik A. Genetic amniocentesis in twin gestation. AM J Obstet Gynecol 1980;138:169.
150. Recommendations and protocols for prenatal diagnosis . En: Carrera JM, Direnzo GC, eds. European Study Group on Prenatal Diagnosis 1993.
151. Tabsh K. Genetic amniocentesis in multiple gestation. A new technique to diagnose monoamniotic twins. Obstet Gynecol 1990; 75:296.
152. Bahado-Singh R, Scmitt R, Hobbins JC. New technique for genetic amniocentesis in twins. Obstet Gynecol 1992;79:304.
153. Jeanty P, Shah D, Roussis P. Single needle insertion in twin amniocentesis. J Ultrasound Med 1990;):511.
154. Stripparo L, Buscaglia M, Longatti L et al. Genetic amniocentesis: 505 cases performed before the sixteenth week of gestation. Prenat Diagn 1990;10:359.
155. Daffos F, Kappela Pavlovsky M, Forestier F. A new procedure for fetal blood sampling in utero: preliminary results of 53 cases. Am J Obstet gynecol 1983;146:985-6
156. Daffos F, Kappela Pavlosvky M, Forestier F.Fetal blood sampling during pregnancy with use of a needle guieded by ultrasound : a study of 606 consecutive cases. Am J Obstet Gynecol 1985; 153: 655-60.
157. Freda VJ, Adamsons Jr K. Exchange transfusions in utero . AM J Obstet Gynecol 1964;89:1721.
158. Hobbins JC, Mahoney MJ. In utero diagnosis of hemoglobinopaties. Tecnique for obtainig fetal blood. N Eng J Med 1974; 290: 1065-7.
159. Maxwell DJ, Johnson Pj, Hurley P. Fetal blood sampling and pregnancy loss in relation to indication. BR J Obstet Gynaecol 1991; 98:892-7
160. Nicolaides KH, Soothill TW, Rodeck CH, Campbell S.Ultasound guided sampling of umbilical cord and placental blood to assess fetal wellbeing. Lancet 1986ª;i:1065-7
161. Rodeck Ch, Campbell S. Umbilical cord insertion as a source of pure fetal blood for prenatal diagnosis. Lancet 1979; i:1244-5
162. Westgren M, Selbing A, Stangenberg M. Fetal intracardiac transfusions in patients with severe Rhesus isoinmmunization. BR Med J Clin Res. 1988;296:885-6
163. Elias S, and Esterly, N.B. Prenatal diagnosis of hereditary skin disorders. Ciln Obstet Gynecol.24;1069,1981
164. Elias S. Use of fetoscopy for the prenatal diagnosis of hereditary skin disorders. Curr.Pobl.Dermatol 16:1,1987
165. Special report: the status of fetoscopy and fetal tissue sampling. Prenat Diagn 4:79,1984
166. Kurjak, A., Alfirevic, Z,and Jurkovic,D. Ultrasonically guided fetal tissue biopsy. Acta Obstet Gynecol Scand 66:523,1987.
167. Golbus M, et al . Prenatal diagnosis of congenitalbullous ichthyosiform erythroderma by fetl skin biopsy. N. Engl J med 302:93,1980
168. Jurkovic D, Jauniaux E, Campbell S, Pandya P, Cardy D, Nicolaides KH. Coelocentesis: a new technique for early prenatal diagnosis. Lancet 1993;341:1623-4
169. Adinolfi M, Davies A, Sharif S, Soothill P, Rodeck CH. Detection of trisomy 18 and Y-derived sequences in fetal nucleated cells obtained by transcervical flushing. Lancet 1993;342:403-4
170. Adinolfi M, Sherlock J, Kemp T, Carritt B, Soothill P, Kingdom J, Rodeck C. Prenatal detection of fetal Rh DNA sequences in transcervical samples. Lancet 1995;345:318-19
171. Warren R, Sánchez L, Hammnond D, Mcleod A. Prenatal sex determination from exfoliated cells found in cervical. Am J Humm Genet 1972;24;22a
172. Lissens W, Sermon K, Staessen C, Van Assche E, Janssenswillen C, Joris H, Van Steirteghem A, Liebaers I. Review: Preimplantation diagnosis of inherited disease. J Inher Metab Dis 1996;19:70923
173. Pembrey ME. In the light of preimplantation genetic diagnosis : Some etical issues in medical genetics revisited. Eur J Human Genet 1998; 6:4-11
174. Harper J. Preimplantation diagnosis of inhereted disssease by embryo biopsy. An Update of teha world figures. J Assist Reprod Genet 1996;13:90-5
175. Delhanty JDA, Griffin DK, Handyside AH, Harper J, Atkinson GHG, Pieters MHEC y cols. Detection of aneuploidy and chromosomal mosaicism in human embryos during preimplantation sex determination by fluorescent in situ hybridizatio (FISH). Hum Mol Genet 1993; 2: 1183-5
176. Delhanty JDA, Handyside AH. The origin of genetic defects in the human under detection in the preimplantation embryo. Hum Reprod Update 1995;1:201-15.
177. Berlisky Y, Ginsberg N, Lifchez A, Valle J, Moise J, Strom CM. Analysis of the first polar body: Preconception genetic diagnosis. Human Reprod 1990;5:826-9.
178. Munné S, Darley T, Sultan KM, Griffo J, Cohen J. The use of first polar bodies of preimplantation diagnosis of aneuploidy. Mol Hum Reprod 1995;1:1014-20.
179. Berlinsky Y, Cieslak J, Freidine M, Ivankhnenko V, Wolf G, Cobalenskaye L, With M, Lifechez A, Kaplan B, Moise J, Ginsberg N, Strom C, Kuliev A. Pregnancies following preconceptional diagnosis of common aneuploidies by fluorescent in situ hybridization. Hum Reprod 1995; 10:19237.
180. Adams MM, Erickson JD, Layde PM, y cols. Down´s syndrome: recent trends in tha United State. Jama 1981;246:758181. Nicolaides KH, Snidjers RJ, Gosden CM y cols. Ultrasonografically detectable markers of fetal chromosomal abnormalities Lancet 1992;340(8821):704.
182. Nicolaides KH, Chawwua L, Brizot M, y cols. Ultrasonografically detectable markers of fetal chromosomal defects. Ultrasound Obstet Gynecol 1993;3:56.
183. Benacerraff BR, Helman R, Frigoletto FD Jr. Sonogrphic identification of second trimester fetuses with Down syndrome. N Engl J Med 1987;317:1371.
184. Borrell A, Costa D, Martinez JM,y cols. Early midtrimester fetal nuchal thickness: effectiveness as a marker of Down syndrome. Am J Obstet Gynecol 1996; 175:45.
185. Dicke JM, Grey DL, Songster GS, Crane JP. Fetal biometry as a screening tool for tha detection of chromosomally abnormal pregnancies. Obstet Gynecol 1989;74:726.
186. Lockwood C, Benacerraff BR, Krinsky A y cols. A sonographic screening method for Down syndrome. Am J Obstet Gynecol 1987;157:803
187. Chah YG, Eckel CJ, Stinson SK, Woods JR. Biparietal diameter / femur length ratio, cephalic indice, and femur measurements : not reliable screening technique for Down syndrome. Obstet gynecol 1990; 75:186
188. Nicolaides KH, Berri S, Snidjers RJ y cols. Fetal lateral cerebral ventriculomegaly : associated malformations and chromosomal defects. Fetal Diagnosis and Therapy 1990;5:5.
189. Touloukian RJ. Intestinal atresia. Clin Perinatol 1978; 5:3.
190. Nyberg DA, Dubinski, Mahoney BS y cols. Ecogenic fetal bowel: Cilical importnace. Radiology 1993;188:527.
191. Benacerraff BR, Harlow BL, Frigoletto FD. Hypoplasia of the middle phalanx of the fith digit: a feature of the second-trimester fetus with Down syndrome. J Ultrasound Med 1990;9:389.
192. Nyberg DA, Resta RG, Luthy DA, y cols. Prenatal sonographic findings of Down syndrome: review of 94 cases. Obstet Gynecol 1990;76:370
193. Nyberg DA, Kramer D, Resta RG, y cols. Prenatal sonographic findigs of trisomy 18: review of 47 cases. J Ultrasound Med 1993;2:103
194. Benacerraf BR , Harlow B, Frogoletto FD. Are choroid plexus cysts an indication for second-trimester amniocentesis ? Am J Obstet Gynecol 1990;162:1001
195. Thurmond AS, Nelson DW, y cols. Enlarged cisterna magna in trisomy 18. Prenatal ultrasound diagnosis. Am J Obstet Gynecol 1990;161:83
196. Nicolaides KH, Salvesen D, Snijders RJM y cols. Stawberry shaped skull: associated malformations and chromosomal defects. Fetal Dian Ther 1991;7:132
197. Pijpers L, Reuss A, Stewart PA, y cols. Fetals cystic higroma: Prenatal diagnostic and management. Obstet Gynecol 1998;72:223
198. Lehman CD, Nyberg DA, Winter TC III y cols. Trisomy 13 syndrome: prenatal US findings in a review of 33 cases. Radiology 1995;194:217
199. Bromley B, Lieberman E, Laboda L, y cols. Echogenic intracrdiac focus: A sonogrphic sign for fetal Down syndrome. Obstet Gynecol 1995;86:998
200. Echogenic foci in the fetal heart: A marker of chromosomal abnormalities. Br L Obstet Gynaecol 1996;193:724

Anterior Siguiente


Por favor ingrese su comentario!